Remove Artificial Intelligence Remove Business Transformation Remove Organization Remove Pharmaceuticals
article thumbnail

Cardinal Health CIO Michelle Greene on simplifying transformation

CIO

Recently, I had the pleasure of speaking with Michelle Greene, who was promoted from SVP of EIT of Cardinal Health’s pharmaceutical segment to CIO last August. Central to that effort is structuring her IT organization to better partner with the business. What follows is an edited version of our conversation.

Analytics 299
article thumbnail

Cardinal Health CIO Michelle Greene on simplifying transformation

CIO

Recently, I had the pleasure of speaking with Michelle Greene, who was promoted from SVP of EIT of Cardinal Health’s pharmaceutical segment to CIO last August. Central to that effort is structuring her IT organization to better partner with the business. What follows is an edited version of our conversation.

Analytics 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IoT, AI, Blockchain: what does the future hold for mobile Healthcare

Apiumhub

Thanks to Artificial Intelligence, Blockchain, and IoT, people have to make fewer visits to the doctor and can stay inter-connected through a computer or mobile phones only. Another report by the 2017 Thales Data Threat confirms that more than 30 percent of healthcare organizations use IoT to store sensitive data.

article thumbnail

And the winners are…. Congratulations to the Sixth Annual Data Impact Awards winners

Cloudera

These awards recognize organizations that transform complex data into actionable insights and illustrate impact to technology, science, health, lifestyle, and community across a wide variety of industries. Congratulations and high fives to every organization that submitted entries. Technical Impact.

article thumbnail

Can data drive more successful R&D in life sciences?

Capgemini

Newly qualified data scientists who haven’t worked in R&D-heavy organizations, including life sciences and healthcare, can struggle to understand the pharmaceutical science and drug approval process, how best to represent and interpret it accurately with their tools, or where to focus their efforts.

Data 98